Cathy Eng Archive
-
March 2, 2023
Eng invited to White House Cancer Moonshot forum
Vanderbilt's Cathy Eng, MD, has been invited to participate in the White House Cancer Moonshot Colorectal Cancer Forum. -
September 13, 2022
Patients had ‘significant and clinically meaningful improvement’ in survival in fruquintinib clinical trial
Patients with metastatic colorectal cancer who had not responded to other treatments had “significant and clinically meaningful improvement” in overall survival when treated with the oral targeted therapy fruquintinib. -
August 18, 2022
Abramson, Eng, Johnson named to new VICC roles
Three physician researchers at Vanderbilt-Ingram Cancer Center are assuming additional leadership roles. -
August 17, 2022
Trial for colorectal cancer drug reaches primary endpoint
A new therapy for metastatic colorectal cancer that has been granted fast track designation by the U.S. Food and Drug Administration has met its primary endpoint of overall survival in a phase 3 clinical trial. -
May 6, 2022
Janet Darnell received a lifesaving lung transplant. Five months later she received lifesaving surgery for colon cancer. She calls herself a “walking miracle.”
Without the lung transplant, the cancer may never have been detected. -
January 25, 2022
Comprehensive framework outlined for addressing early-onset colorectal cancer research
New research from Vanderbilt sets a comprehensive framework for addressing research challenges and patient needs for people under 50 with colorectal cancer. -
September 23, 2021
Eng named co-chair of NCI clinical trials steering committee
Vanderbilt's Cathy Eng, MD, has been elected co-chair of the National Cancer Institute (NCI) Gastrointestinal Cancer Steering Committee.